查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1386417

創傷後壓力症候群 (PTSD) 市場報告：2030 年趨勢、預測與競爭分析

Post-Traumatic Stress Disorder (PTSD) Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

創傷後壓力症候群（PTSD）的趨勢和預測

預計到 2030 年，全球創傷後壓力症候群 (PTSD) 市場將達到約 14 億美元，2024 年至 2030 年年複合成長率為 4.6%。這個市場的主要促進因素是創傷後壓力症候群的盛行率不斷上升、人們對心理健康問題的認知不斷增強，以及由於創傷後壓力症候群治療的研發活動激增而對心理健康服務的需求不斷增加混亂，需求不斷增加。由於醫院和診所市場的機遇，全球創傷後壓力症候群（PTSD）市場的未來性廣闊。

創傷後壓力症候群 (PTSD) 市場洞察

Lucintel 預測，由於該年齡層患者數量眾多、成年人口中精神疾病盛行率不斷上升以及創傷經歷增加，因此在預測期內，成年人口將繼續佔據市場的很大一部分。

在這個市場中，醫院可能仍佔較大佔有率，因為它們在初級衛生保健機構中診斷和治療創傷後壓力症候群病例方面的重要性，以及管理急性危機的能力。

由於創傷後壓力症候群的盛行率不斷上升以及對精神衛生保健服務的需求不斷增加，北美將繼續成為最大的地區。

本報告回答了 11 個關鍵問題：

  • Q.1. 細分市場中最有前途和高成長的機會是什麼？
  • Q.2.哪個細分市場將以更快的速度成長？為什麼？
  • Q.3.您認為哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要因素有哪些？市場的主要挑戰和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去年度發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章 執行摘要

第2章 全球創傷後壓力症候群（PTSD）市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球創傷後壓力症候群（PTSD）市場趨勢（2018-2023）與預測（2024-2030）
  • 按產品類型分類的全球創傷後壓力症候群 (PTSD) 市場
    • 抗憂鬱症
    • 認知療法
    • 抗焦慮藥
    • 暴露療法
    • 眼動減敏與再處理（EMDR）
    • 治療方法PSTD
  • 按年齡分類的全球創傷後壓力症候群 (PTSD) 市場
    • 孩子
    • 成人
  • 全球創傷後壓力症候群 (PTSD) 市場（按最終用途）
    • 醫院
    • 診所

第4章 2018-2030年分地區市場趨勢及預測分析

  • 全球創傷後壓力症候群 (PTSD) 市場（按地區）
  • 北美創傷後壓力症候群（PTSD）市場
  • 歐洲創傷後壓力症候群（PTSD）市場
  • 亞太地區創傷後壓力症候群（PTSD）市場
  • 其他區域創傷後壓力症候群 (PTSD) 市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 按產品類型分類的全球創傷後壓力症候群 (PTSD) 市場成長機會
    • 按年齡分類的全球創傷後壓力症候群 (PTSD) 市場成長機會
    • 全球創傷後壓力症候群 (PTSD) 市場成長機會（按最終用途）
    • 全球創傷後壓力症候群 (PTSD) 市場成長機會（按地區）
  • 全球創傷後壓力症候群（PTSD）市場的新趨勢
  • 戰略分析
    • 新產品開發
    • 全球創傷後壓力症候群 (PTSD) 市場容量擴張
    • 全球創傷後壓力症候群 (PTSD) 市場的合併、收購和合資企業
    • 認證和許可

第7章 主要企業概況

  • GlaxoSmithKline
  • Pfizer
  • Eli Lilly & Company
  • Azevan Pharmaceuticals
  • Otsuka Pharmaceutical
  • AstraZeneca
  • Neurocrine Biosciences
  • Nuvo Pharmaceuticals
  • Marinus Pharmaceuticals
  • Tonix Pharmaceuticals
簡介目錄

Post-Traumatic Stress Disorder (PTSD) Trends and Forecast

The future of the global post-traumatic stress disorder (PTSD) market looks promising with opportunities in the hospital and clinic markets. The global post-traumatic stress disorder (PTSD) market is expected to reach an estimated $1.4 billion by 2030 with a CAGR of 4.6% from 2024 to 2030. The major drivers for this market are increasing prevalence of post-traumatic stress disorders, rising awareness towards mental health issues, and growing demand of mental health services along with surhing R&D activities for treatment of post-traumatic stress disorders.

A more than 150-page report is developed to help in your business decisions.

Post-Traumatic Stress Disorder (PTSD) by Segment

The study includes a forecast for the global post-traumatic stress disorder (PTSD) by product type, age group, end use, and region.

Post-Traumatic Stress Disorder (PTSD) Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Antidepressants
  • Cognitive Therapy
  • Anti-Anxiety Drugs
  • Exposure Therapy
  • Eye Movement Desensitization & Reprocessing (EMDR)
  • PSTD Therapeutics

Post-Traumatic Stress Disorder (PTSD) Market by Age Group [Shipment Analysis by Value from 2018 to 2030]:

  • Children
  • Adult

Post-Traumatic Stress Disorder (PTSD) Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Clinics

Post-Traumatic Stress Disorder (PTSD) Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Post-Traumatic Stress Disorder (PTSD) Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies post-traumatic stress disorder (PTSD) companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the post-traumatic stress disorder (PTSD) companies profiled in this report include-

  • Glaxosmithkline
  • Pfizer
  • Eli Lilly & Company
  • Azevan Pharmaceuticals
  • Otsuka Pharmaceutical
  • Astrazeneca
  • Neurocrine Biosciences
  • Nuvo Pharmaceuticals
  • Marinus Pharmaceuticals
  • Tonix Pharmaceuticals

Post-Traumatic Stress Disorder (PTSD) Market Insights

Lucintel forecasts that adult will remain the larger semgent over the forecast period due to large number of patients in this age group, growing mental health disorder cases in the adult group, and rising traumatic experiences.

Within this market, hospitals will remain the larger segment due to their importance in primary healthcare settings for the diagnosis and treatment of post-traumatic stress disorder cases along with their capabilities to manage acute crisis.

North America will remain the largest region due to increasing prevalence of post-traumatic stress disorder and growing demand of mental healthcare services in the region.

Features of the Global Post-Traumatic Stress Disorder (PTSD) Market

Market Size Estimates: Post-traumatic stress disorder (PTSD) market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Post-traumatic stress disorder (PTSD) market size by product type, age group, end use, and region in terms of value ($B).

Regional Analysis: Post-traumatic stress disorder (PTSD) market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, age groups, end uses, and regions for the post-traumatic stress disorder (PTSD) market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the post-traumatic stress disorder (PTSD) market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the post-traumatic stress disorder (PTSD) market size?

Answer: The global post-traumatic stress disorder (PTSD) market is expected to reach an estimated $1.4 billion by 2030.

Q.2 What is the growth forecast for post-traumatic stress disorder (PTSD) market?

Answer: The global post-traumatic stress disorder (PTSD) market is expected to grow with a CAGR of 4.6% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the post-traumatic stress disorder (PTSD) market?

Answer: The major drivers for this market are increasing prevalence of post-traumatic stress disorders, rising awareness towards mental health issues, and growing demand of mental health services along with surhing R&D activities for treatment of post-traumatic stress disorders.

Q4. What are the major segments for post-traumatic stress disorder (PTSD) market?

Answer: The future of the post-traumatic stress disorder (PTSD) market looks promising with opportunities in the hospital and clinic markets.

Q5. Who are the key post-traumatic stress disorder (PTSD) market companies?

Answer: Some of the key post-traumatic stress disorder (PTSD) companies are as follows:

  • Glaxosmithkline
  • Pfizer
  • Eli Lilly & Company
  • Azevan Pharmaceuticals
  • Otsuka Pharmaceutical
  • Astrazeneca
  • Neurocrine Biosciences
  • Nuvo Pharmaceuticals
  • Marinus Pharmaceuticals
  • Tonix Pharmaceuticals

Q6. Which post-traumatic stress disorder (PTSD) market segment will be the largest in future?

Answer: Lucintel forecasts that adult will remain the larger semgent over the forecast period due to large number of patients in this age group, growing mental health disorder cases in the adult group, and rising traumatic experiences.

Q7. In post-traumatic stress disorder (PTSD) market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to increasing prevalence of post-traumatic stress disorder and growing demand of mental healthcare services in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the post-traumatic stress disorder (PTSD) market by product type (antidepressants, cognitive therapy, anti-anxiety drugs, exposure therapy, eye movement desensitization & reprocessing (EMDR), and PSTD therapeutics), age group (children and adult), end use (hospitals and clinics), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Post-Traumatic Stress Disorder (PTSD) Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Post-Traumatic Stress Disorder (PTSD) Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Post-Traumatic Stress Disorder (PTSD) Market by Product Type
    • 3.3.1: Antidepressants
    • 3.3.2: Cognitive Therapy
    • 3.3.3: Anti-Anxiety Drugs
    • 3.3.4: Exposure Therapy
    • 3.3.5: Eye Movement Desensitization & Reprocessing (EMDR)
    • 3.3.6: PSTD therapeutics
  • 3.4: Global Post-Traumatic Stress Disorder (PTSD) Market by Age Group
    • 3.4.1: Children
    • 3.4.2: Adult
  • 3.5: Global Post-Traumatic Stress Disorder (PTSD) Market by End Use
    • 3.5.1: Hospitals
    • 3.5.2: Clinics

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Post-Traumatic Stress Disorder (PTSD) Market by Region
  • 4.2: North American Post-Traumatic Stress Disorder (PTSD) Market
    • 4.2.1: North American Post-Traumatic Stress Disorder (PTSD) Market by Age Group: Children and Adult
    • 4.2.2: North American Post-Traumatic Stress Disorder (PTSD) Market by End Use: Hospitals and Clinics
  • 4.3: European Post-Traumatic Stress Disorder (PTSD) Market
    • 4.3.1: European Post-Traumatic Stress Disorder (PTSD) Market by Age Group: Children and Adult
    • 4.3.2: European Post-Traumatic Stress Disorder (PTSD) Market by End Use: Hospitals and Clinics
  • 4.4: APAC Post-Traumatic Stress Disorder (PTSD) Market
    • 4.4.1: APAC Post-Traumatic Stress Disorder (PTSD) Market by Age Group: Children and Adult
    • 4.4.2: APAC Post-Traumatic Stress Disorder (PTSD) Market by End Use: Hospitals and Clinics
  • 4.5: ROW Post-Traumatic Stress Disorder (PTSD) Market
    • 4.5.1: ROW Post-Traumatic Stress Disorder (PTSD) Market by Age Group: Children and Adult
    • 4.5.2: ROW Post-Traumatic Stress Disorder (PTSD) Market by End Use: Hospitals and Clinics

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Post-Traumatic Stress Disorder (PTSD) Market by Product Type
    • 6.1.2: Growth Opportunities for the Global Post-Traumatic Stress Disorder (PTSD) Market by Age Group
    • 6.1.3: Growth Opportunities for the Global Post-Traumatic Stress Disorder (PTSD) Market by End Use
    • 6.1.4: Growth Opportunities for the Global Post-Traumatic Stress Disorder (PTSD) Market by Region
  • 6.2: Emerging Trends in the Global Post-Traumatic Stress Disorder (PTSD) Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Post-Traumatic Stress Disorder (PTSD) Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Post-Traumatic Stress Disorder (PTSD) Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: GlaxoSmithKline
  • 7.2: Pfizer
  • 7.3: Eli Lilly & Company
  • 7.4: Azevan Pharmaceuticals
  • 7.5: Otsuka Pharmaceutical
  • 7.6: AstraZeneca
  • 7.7: Neurocrine Biosciences
  • 7.8: Nuvo Pharmaceuticals
  • 7.9: Marinus Pharmaceuticals
  • 7.10: Tonix Pharmaceuticals